Literature DB >> 3332192

Treatment of adult T cell leukemia with mega-dose cyclophosphamide and total body irradiation followed by allogeneic bone marrow transplantation.

R Sobue1, T Yamauchim, K Miyamura, H Sao, T Tahara, H Yoshikawa, S Yoshikawa, Y Morishima, Y Kodera.   

Abstract

A 43-year-old patient with adult T cell leukemia (ATL) was treated with mega-dose cyclophosphamide and total body irradiation (TBI) followed by bone marrow transplantation (BMT) from his HLA-identical sibling who was not a carrier of ATL virus. After BMT, ATL cells rapidly decreased and disappeared, and the engraftment of marrow was confirmed on day 20. The patient showed normal hematologic recovery. However, he died on day 205 with interstitial pneumonitis caused by cytomegalovirus infection. Neither autopsy findings nor serologic and cytologic examinations showed any evidence of ATL relapse after BMT. This pilot study suggests that mega-dose chemotherapy and TBI followed by allogeneic BMT should be considered for such treatment of ATL.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3332192

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


  7 in total

Review 1.  Human T cell lymphotropic virus-associated leukemia/lymphoma.

Authors:  Lee Ratner
Journal:  Curr Opin Oncol       Date:  2005-09       Impact factor: 3.645

Review 2.  Allogeneic stem cell transplantation for adult T-cell leukemia/lymphoma.

Authors:  Jun Okamura; Naokuni Uike; Atae Utsunomiya; Ryuji Tanosaki
Journal:  Int J Hematol       Date:  2007-08       Impact factor: 2.490

3.  Eradication of virus-infected T-cells in a case of adult T-cell leukemia/lymphoma by nonmyeloablative peripheral blood stem cell transplantation with conditioning consisting of low-dose total body irradiation and pentostatin.

Authors:  Yasunobu Abe; Shinji Yashiki; Ilseung Choi; Keiichi Hara; Takamitsu Matsushima; Junji Nishimura; Shoichi Inaba; Hajime Nawata; Koichiro Muta
Journal:  Int J Hematol       Date:  2002-07       Impact factor: 2.490

4.  Clinical efficacy of all-trans retinoic acid for treating adult T cell leukemia.

Authors:  Yasuhiro Maeda; Terufumi Yamaguchi; Yasuki Hijikata; Miyako Tanaka; Chikara Hirase; Shunsuke Takai; Yasuyoshi Morita; Tetsuaki Sano; Jun-Ichi Miyatake; Yoichi Tatsumi; Akihisa Kanamaru
Journal:  J Cancer Res Clin Oncol       Date:  2007-11-15       Impact factor: 4.553

Review 5.  Progress in Allogeneic Hematopoietic Cell Transplantation in Adult T-Cell Leukemia-Lymphoma.

Authors:  Atae Utsunomiya
Journal:  Front Microbiol       Date:  2019-10-01       Impact factor: 5.640

6.  Transplant-related complications are impediments to the success of allogeneic hematopoietic stem cell transplantation for adult T cell leukemia patients in non-complete remission.

Authors:  Shouhei Tomori; Satoko Morishima; Yukiko Nishi; Sawako Nakachi; Keita Tamaki; Kazuho Morichika; Iori Tedokon; Natsuki Shimabukuro; Taeko Hanashiro; Sakiko Kitamura; Sachie Uchibori; Riko Miyagi; Takashi Miyagi; Kaori Karimata; Masayo Ohama; Atsushi Yamanoha; Takeaki Tomoyose; Kennosuke Karube; Takuya Fukushima; Hiroaki Masuzaki
Journal:  Bone Marrow Transplant       Date:  2019-09-18       Impact factor: 5.483

Review 7.  Current status of therapeutic approaches to adult T-cell leukemia.

Authors:  Takayuki Ishikawa
Journal:  Int J Hematol       Date:  2003-11       Impact factor: 2.319

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.